Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 Inhalation Powder and the Individual Components Delivered Once-Daily via a Novel Dry Powder Inhaler in Subjects with Chronic Obstructive Pulmonary Disease
umeclidinium bromide/vilanterol
DB2113361
NCT01313637
Pulmonary Disease, Chronic Obstructive
Phase 3
 
March 2014

Powered by ideaPoint, Inc.